We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+10.9%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$27.8B
AUM Growth
+$3.36B
Cap. Flow
+$723M
Cap. Flow %
2.6%
Top 10 Hldgs %
55.63%
Holding
2,156
New
217
Increased
776
Reduced
764
Closed
175

Sector Composition

Rank Sector Weight
1 Financials 4.74%
2 Technology 4.11%
3 Healthcare 2.19%
4 Energy 2.03%
5 Consumer Discretionary 1.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LSCC icon
1051
Lattice Semiconductor
LSCC
$17.6B
$477K ﹤0.01%
40,000
-30,486
-43% -$304K
COKE icon
1052
Coca-Cola Consolidated
COKE
$12.3B
$475K ﹤0.01%
16,500
+330
+2% +$7.54K
UHAL icon
1053
U-Haul Holding Co
UHAL
$14B
$475K ﹤0.01%
12,800
NBIX icon
1054
Neurocrine Biosciences
NBIX
$17.7B
$474K ﹤0.01%
5,383
+62
+1% +$5.18K
EVT icon
1055
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$2.06B
$473K ﹤0.01%
21,219
-992
-4% -$21.1K
PSEC icon
1056
Prospect Capital
PSEC
$1.06B
$473K ﹤0.01%
72,531
-1,779
-2% -$11.8K
TBI
1057
Trueblue
TBI
$234M
$473K ﹤0.01%
20,000
XAR icon
1058
State Street SPDR S&P Aerospace & Defense ETF
XAR
$6.07B
$473K ﹤0.01%
5,157
+162
+3% +$14.5K
TVIX
1059
DELISTED
VelocityShares Daily 2x VIX Short Term ETN
TVIX
$473K ﹤0.01%
+1,810
New +$688K
TARO
1060
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$472K ﹤0.01%
4,365
TTM
1061
DELISTED
Tata Motors Limited
TTM
$472K ﹤0.01%
37,564
-884
-2% -$11K
FBGX
1062
DELISTED
UBS AG FI Enhanced Large Cap Growth ETN
FBGX
$471K ﹤0.01%
1,879
+299
+19% +$68.2K
CASY icon
1063
Casey's General Stores
CASY
$31.9B
$470K ﹤0.01%
3,649
+1,254
+52% +$164K
SMG icon
1064
ScottsMiracle-Gro
SMG
$4.03B
$470K ﹤0.01%
5,986
+333
+6% +$25.1K
SUPN icon
1065
Supernus Pharmaceuticals
SUPN
$2.68B
$470K ﹤0.01%
13,426
+4,602
+52% +$171K
BF.B icon
1066
Brown-Forman Class B
BF.B
$12B
$469K ﹤0.01%
8,889
-1,010
-10% -$49K
MNKD icon
1067
MannKind Corp
MNKD
$1.28B
$468K ﹤0.01%
237,650
-2,904
-1% -$4.6K
TRP icon
1068
TC Energy
TRP
$73.5B
$468K ﹤0.01%
10,418
+77
+0.7% +$3.31K
NKX icon
1069
Nuveen California AMT-Free Quality Municipal Income Fund
NKX
$651M
$467K ﹤0.01%
+33,532
New +$450K
UPLD icon
1070
Upland Software
UPLD
$12M
$466K ﹤0.01%
1,100
FDS icon
1071
Factset
FDS
$9.05B
$464K ﹤0.01%
1,868
-114
-6% -$25.5K
KBE icon
1072
State Street SPDR S&P Bank ETF
KBE
$1.64B
$464K ﹤0.01%
11,098
+2,502
+29% +$107K
SPH icon
1073
Suburban Propane Partners
SPH
$1.23B
$464K ﹤0.01%
20,700
-508
-2% -$11.2K
FVD icon
1074
First Trust Value Line Dividend Fund
FVD
$8.29B
$463K ﹤0.01%
14,265
+332
+2% +$10.4K
OMCL icon
1075
Omnicell
OMCL
$1.86B
$463K ﹤0.01%
5,729
-1,079
-16% -$80.8K

Similar funds

Creative Planning's Q1 2019 Portfolio in Review

As of Q1 2019, Creative Planning held 2,156 positions worth $27.8B, up 14% from $24.4B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Creative Planning's Q1 2019 filing shows 217 new, 776 increased, 764 reduced and 175 closed positions. Its largest new stake was Intercept Pharmaceuticals, Inc.: 33,175 shares worth $3.71M. The largest sale was Vanguard Mid-Cap ETF, an estimated $63.3M.

By sector, the portfolio is most concentrated in Financials at 4.7% of assets, down from 5.2% a quarter earlier, followed by Technology and Healthcare.

  • Creative Planning's largest Q1 2019 buy was Intercept Pharmaceuticals, Inc.: 33,175 shares worth $3.71M.
  • Creative Planning added most to iShares Core US Aggregate Bond ETF in Q1 2019, an estimated $157M increase.
  • Creative Planning's biggest Q1 2019 reduction was Vanguard Mid-Cap ETF, cutting an estimated $63.3M.
  • Creative Planning fully exited Kforce in Q1 2019, selling an estimated $3.23M.
  • Creative Planning's ten largest holdings make up 56% of its $27.8B portfolio in Q1 2019.
  • Creative Planning opened 217 new positions and closed 175 in Q1 2019.
  • Creative Planning's portfolio value rose 14% quarter-over-quarter to $27.8B.

Based on Creative Planning's 13F filing for Q1 2019, filed 24 Apr 2019.